RemeGen Co Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Yantai, Shandong and currently employs 2,999 full-time employees. The company went IPO on 2020-11-09. RemeGen Co Ltd is a China-based company principally engaged in biopharmaceutical research, biopharmaceutical service, biopharmaceutical production and sale. The firm focuses on therapeutic antibody drugs such as antibody-drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company’s main products include telitacicept, disitamab vedotin, RC28-E and others. The firm's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The firm mainly operates its businesses in the domestic and overseas markets.
09995.HK stock price ended at $92.9 on 화요일, after dropping 2.42%
On the latest trading day Jan 20, 2026, the stock price of 09995.HK fell by 2.42%, dropping from $95.30 to $92.90. During the session, the stock saw a volatility of 4.13%, with prices oscillating between a daily low of $92.00 and a high of $95.80. On the latest trading day, the trading volume for 09995.HK rose by 803.0K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 3.7M shares were traded, with a market value of approximately $19.3B.
09995.HK 기술적 시그널
기술적 시그널 요약
구매 신호 4
중립 신호 2
매도 신호 1
Strong Sell
Sell
Neutral
Buy
Strong Buy
09995.HK은 현재 4개의 매수 신호와 1개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 하락 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 -5.01%입니다. 전반적으로 기술적 지표들은 중기적으로 Buy 전망을 나타내고 있습니다.
09995.HK에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 09995.HK 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.